Search for new tools to combat Gram-negative resistant bacteria among amine derivatives of 5-arylidenehydantoin.
暂无分享,去创建一个
J. Handzlik | K. Kieć‐Kononowicz | J. Pagés | E. Szymańska | J. Chevalier | E. Pękala | Sandrine Alibert | Ewa Otrębska
[1] J. Karolak-Wojciechowska,et al. Synthesis and SAR-study for novel arylpiperazine derivatives of 5-arylidenehydantoin with α₁-adrenoceptor antagonistic properties. , 2012, Bioorganic & medicinal chemistry.
[2] J. Handzlik,et al. Antiarrhythmic properties of phenylpiperazine derivatives of phenytoin with α₁-adrenoceptor affinities. , 2012, Bioorganic & medicinal chemistry.
[3] J. Handzlik,et al. Amine-alkyl derivatives of hydantoin: new tool to combat resistant bacteria. , 2011, European journal of medicinal chemistry.
[4] J. Handzlik,et al. Strategies for bypassing the membrane barrier in multidrug resistant Gram‐negative bacteria , 2011, FEBS letters.
[5] J. Pagés,et al. An original deal for new molecule: reversal of efflux pump activity, a rational strategy to combat gram-negative resistant bacteria. , 2011, Current medicinal chemistry.
[6] J. Handzlik,et al. Pharmacophore models based studies on the affinity and selectivity toward 5-HT1A with reference to α1-adrenergic receptors among arylpiperazine derivatives of phenytoin. , 2011, Bioorganic & medicinal chemistry.
[7] J. Handzlik,et al. Search for influence of spatial properties on affinity at α1-adrenoceptor subtypes for phenylpiperazine derivatives of phenytoin. , 2010, Bioorganic & medicinal chemistry letters.
[8] K. Kieć‐Kononowicz,et al. Synthesis of 5-arylidene-2-amino-4-azolones and evaluation of their anticancer activity. , 2010, Bioorganic & medicinal chemistry.
[9] K. Kieć‐Kononowicz,et al. Crystallographic studies of ( Z ) and ( E ) isomers of 2-amino-5-(2-chlorobenzylidene)-1-methyl-1H-imidazol-4(5H)-one , 2010 .
[10] K. Kieć‐Kononowicz,et al. Crystallographic and spectroscopic studies of 5-arylidene-2-amino-imidazol-4-ones , 2009 .
[11] H. Nikaido,et al. Mechanisms of RND multidrug efflux pumps. , 2009, Biochimica et biophysica acta.
[12] J. Pagés,et al. Mechanisms of drug efflux and strategies to combat them: challenging the efflux pump of Gram-negative bacteria. , 2009, Biochimica et biophysica acta.
[13] J. Handzlik,et al. Synthesis, alpha 1-adrenoceptor antagonist activity, and SAR study of novel arylpiperazine derivatives of phenytoin. , 2008, Bioorganic & medicinal chemistry.
[14] J. Frère,et al. Treatment of health-care-associated infections caused by Gram-negative bacteria: a consensus statement. , 2008, The Lancet. Infectious diseases.
[15] M. Totrov,et al. Waltzing transporters and 'the dance macabre' between humans and bacteria , 2007, Nature Reviews Drug Discovery.
[16] E. Mini,et al. Pharmacological strategies for overcoming multidrug resistance. , 2006, Current drug targets.
[17] J. Pagés,et al. Quinoline derivatives as promising inhibitors of antibiotic efflux pump in multidrug resistant Enterobacter aerogenes isolates. , 2006, Current drug targets.
[18] I. Paulsen,et al. Microbial drug efflux proteins of the major facilitator superfamily. , 2006, Current drug targets.
[19] K. Kieć‐Kononowicz,et al. Synthesis, structure-activity relationship of some new anti-arrhythmic 5-arylidene imidazolidine-2,4-dione derivatives. , 2005, European journal of medicinal chemistry.
[20] K. Kieć‐Kononowicz,et al. Synthesis, structure and antiarrhythmic properties evaluation of new basic derivatives of 5,5-diphenylhydantoin. , 2003, European journal of medicinal chemistry.
[21] S. Dei,et al. The medicinal chemistry of multidrug resistance (MDR) reversing drugs. , 2002, Farmaco.
[22] K. Kieć‐Kononowicz,et al. Antimycobacterial activity of 5-arylidene aromatic derivatives of hydantoin. , 2002, Farmaco.
[23] K. Kieć‐Kononowicz,et al. Antimicrobial activity of 5-arylidene aromatic derivatives of hydantoin. Part 2. , 2002, Farmaco.
[24] J. Marton,et al. Preparation and fungicidal activity of 5-substituted hydantoins and their 2-thio analogs , 1993 .
[25] K. Ang,et al. NMR spectroscopic study of configurations and conformations of 5-pyridylmethylenehydantoins , 1990 .
[26] K. Ang,et al. (Z)- and (E)-5-Arylmethylenehydantoins: spectroscopic properties and configuration assignment , 1986 .